Potential celiac disease drug that breaks down gluten protects against damage to the small intestine
Article originally published on BeyondCeliac.org by Amy Ratner, director of scientific affairs A drug designed to break gluten into...
News & Articles
Search
Beyond Celiac
- Oct 13, 2020
- 1 min
PHASE 2 STUDY RELAUNCHING IN NOVEMBER
by Kate Avery, MPH, Director of Research & Patient Engagement ImmunogenX put the Solutions for Celiac study (NCT04243551) on hold in...
53
Celiac Disease Foundation
- Feb 13, 2020
- 2 min
Celiac Disease Patients on a Gluten-Free Diet Still Ingest Gluten
Persistent gluten exposure is known to lead to lifelong health issues in people with celiac disease, including anemia, malnutrition, and...
43
Beyond Celiac
- Feb 3, 2020
- 2 min
NEW PHASE 2 CLINICAL TRIAL FOR SYMPTOMATIC CELIAC DISEASE PATIENTS LAUNCHES
Testing of latiglutenase to relieve symptoms in celiac disease patients continues with the launch of a clinical trial in December This...
195
Beyond Celiac
- Jan 24, 2020
- 3 min
POTENTIAL DRUG FOR CELIAC DISEASE IMPROVES SYMPTOMS AND QUALITY OF LIFE IN SOME PATIENTS
Study participants whose blood tests showed gluten exposure saw latiglutenase benefits
42
Celiac Disease Foundation
- Dec 18, 2019
- 2 min
Latiglutenase for Celiac Disease Shows Symptom, Quality of Life Improvement
ImmunogenX, a clinical stage biotherapeutics company, has published the results of their phase 2 trial testing latiglutenase—an orally...
52
Beyond Celiac
- Nov 28, 2017
- 3 min
BREAKING DOWN GLUTEN TO TREAT CELIAC DISEASE
Investigation of new drug that could help patients struggling with symptoms gets NIH grant
20
Sign up for our clinical trial today